Based on in vitro treatment of KCs with hrSFRP2 showing increased KRT10 expression, a marker of KC differentiation31 and cell cycle progression, we predict that a role of SFRP2 in TE is to stimulate KC differentiation. The gene discussed is KRT10; the disease is dry eye syndrome.